Pathology of balloon‐expandable transcatheter aortic valves
Kazuyuki Yahagi(CVPath Institute), Aloke V. Finn(University of Maryland, Baltimore), Elena Ladich(CVPath Institute), Renu Virmani(CVPath Institute), Howard C. Herrmann(University of Pennsylvania), Robert Kutys(CVPath Institute), Hiroyoshi Mori(Showa University Fujigaoka Hospital), Martin B. Leon(Columbia University Irving Medical Center), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Craig R. Smith(University of Arizona), Lars G. Svensson(Cleveland Clinic)
Cited by 28
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
EuroSCORE II
|European Journal of Cardio-Thoracic Surgery|2012|2.9k